C. Fernández-Chacón

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen.

A. Lluch, J. Zaluski, M. Martín, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Toxicity and health-related quality of life (HRQoL) in node-negative breast cancer (BC) patients (pts) receiving adjuvant treatment with TAC (docetaxel, doxorubicin, cyclophosphamide) or FAC (5-fluorouracil, doxorubicin, cyclophosphamide): Impact of adding prophylactic growth factors (GF) to TAC. GE

A. Lluch, M. Martín, M. Ramos, 2005 .

Cetuximab-induced hypertrichosis of the scalp and eyelashes.

P. Jaen, D. Ma, C. Fernández-Chacón, 2010, Journal of the American Academy of Dermatology.

Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer

J. Jimenez-Heffernan, S. Mok, M. López-Cabrera, 2017, The Journal of pathology.

The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis

J. Jimenez-Heffernan, M. López-Cabrera, P. Sandoval, 2015, Cancers.

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

C. Balañà, M. Martínez-García, R. Andrés, 2012, Anti-cancer drugs.

Imaging of herpes simplex virus thymidine kinase (HSVtk) gene expression with positron emission tomography (PET)

C. Fernández-Chacón, 2000 .